Sources of Support and Conflicts of Interest: This study was supported by the Fulbright African Regional Research Program (Meyer), American Academy of Neurology Practice Research Training Fellowship (Meyer), Doris Duke International Clinical Research Fellowship (Cettomai), and American Medical Association Foundation Seed Grant (Cettomai). In addition, this study was supported by the Fogarty International Clinical Research Fellowship (Meyer, Kwasa) (5 R24 TW00798; 3 R24 TW00798-02S1) from the National Institutes of Health, Fogarty International Center through Vanderbilt University, the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), Office of the Director, National Institutes of Health and the National Institute of Mental Health (NIMH). Dr. Deanna Cettomai has received research support from the Doris Duke Charitable Foundation and an NIH/Johns Hopkins Pre-Doctoral Clinical Research Training Program T32 grant. Dr. Judith Kwasa has received research support from the NIH Fogarty International Clinical Research Scholarship. Dr. Gretchen Birbeck has received NIH research support, including travel and meeting attendance related to R01, R21 and K23 awards, as well as research support from the Doris Duke Charitable Fund. Dr. Richard Price has received support from NIH/NIMH research grants, an investigator-initiated research grant from Merck and a lecture honorarium from Abbott. Dr. Craig Cohen has received funds from Osel, Inc. to conduct a Phase 2a clinical trial of LACTIN-V, a vaginal probiotic to prevent recurrent bacterial vaginosis. Ms. Caroline Kendi has nothing to disclose. Dr. Elizabeth Bukusi has received funding from NIH, CDC, the Bill and Melinda Gates Foundation, and the International Partnership for Microbicides. Dr. Ana-Claire Meyer has received research support from the Fulbright African Regional Research Program, NIH Fogarty International Clinical Research Fellowship (5 R24 TW00798; 3 R24 TW00798-02S1). She is currently the recipient of a K01 and R21 from NIH.
Screening for HIV-associated peripheral neuropathy in resource-limited settings
Article first published online: 27 AUG 2013
Copyright © 2013 Wiley Periodicals, Inc.
Muscle & Nerve
Volume 48, Issue 4, pages 516–524, October 2013
How to Cite
Cettomai, D., Kwasa, J. K., Birbeck, G. L., Price, R. W., Cohen, C. R., Bukusi, E. A., Kendi, C. and Meyer, A.-C. L. (2013), Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle Nerve, 48: 516–524. doi: 10.1002/mus.23795
This work was funded by the NIH but is not a US government work, nor is it public domain. It does need to be made available under the public access laws.
- Issue published online: 23 SEP 2013
- Article first published online: 27 AUG 2013
- Accepted manuscript online: 30 JAN 2013 10:50PM EST
- Manuscript Accepted: 14 JAN 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.